Christopher Heelan
Analyst-Equity at Grantham Mayo Van Otterloo & Co LLC (Research)
Profile
Christopher Heelan currently works at Grantham Mayo Van Otterloo & Co LLC (Research), as Quantitative Research Analyst from 2020.
Dr. Heelan received his graduate degree in 2014 and doctorate degree in 2018 from Brown University and undergraduate degree in 2011 from Vanderbilt University.
Christopher Heelan active positions
| Companies | Position | Start |
|---|---|---|
Grantham Mayo Van Otterloo & Co LLC (Research)
 Grantham Mayo Van Otterloo & Co LLC (Research) Investment ManagersFinance Grantham, Mayo, Van Otterloo Co. LLC (GMO) is a privately-held global investment management firm and registered investment advisor located in Boston, Massachusetts. The firm provides services to clients in the corporate, public, endowment, and foundation marketplaces. GMO's investment divisions include international active equity, forestry, asset allocation, global fixed-income, emerging equity and quantitative equity. Their research division, GMO Research, provides coverage of a variety of sectors, including but not limited to: health technology, finance, consumer non-durables, energy minerals, technology services and forestry products. | Analyst-Equity | 2020-06-30 |
Training of Christopher Heelan
| Brown University | Doctorate Degree |
| Vanderbilt University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Grantham Mayo Van Otterloo & Co LLC (Research)
Grantham Mayo Van Otterloo & Co LLC (Research) Investment ManagersFinance Grantham, Mayo, Van Otterloo Co. LLC (GMO) is a privately-held global investment management firm and registered investment advisor located in Boston, Massachusetts. The firm provides services to clients in the corporate, public, endowment, and foundation marketplaces. GMO's investment divisions include international active equity, forestry, asset allocation, global fixed-income, emerging equity and quantitative equity. Their research division, GMO Research, provides coverage of a variety of sectors, including but not limited to: health technology, finance, consumer non-durables, energy minerals, technology services and forestry products. | Finance |
- Stock Market
- Insiders
- Christopher Heelan
